Seol-heui O. Han

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 119 publications

Longitudinal CDR-Sum of Boxes trajectories in mild cognitive impairment reveal functional heterogeneity beyond cognitive decline: A latent class growth analysis.

Longitudinal CDR-Sum of Boxes trajectories in mild cognitive impairment reveal functional heterogeneity beyond cognitive decline: A latent class growth analysis.

Journal: Journal of Alzheimer's disease : JAD

Published: September 03, 2026

Future Therapeutic Strategies for Alzheimer's Disease: Focus on Behavioral and Psychological Symptoms.

Future Therapeutic Strategies for Alzheimer's Disease: Focus on Behavioral and Psychological Symptoms.

Journal: International journal of molecular sciences

Published: September 24, 2024

GSP1-111 Modulates the Microglial M1/M2 Phenotype by Inhibition of Toll-like Receptor 2: A Potential Therapeutic Strategy for Depression.

GSP1-111 Modulates the Microglial M1/M2 Phenotype by Inhibition of Toll-like Receptor 2: A Potential Therapeutic Strategy for Depression.

Journal: International journal of molecular sciences

Published: September 04, 2024

Volume and Permeability of White Matter Hyperintensity on Cognition: A DCE Imaging Study of an Older Cohort With and Without Cognitive Impairment.

Volume and Permeability of White Matter Hyperintensity on Cognition: A DCE Imaging Study of an Older Cohort With and Without Cognitive Impairment.

Journal: Journal of magnetic resonance imaging : JMRI

Published: October 21, 2023

Blood-brain barrier breakdown is linked to tau pathology and neuronal injury in a differential manner according to amyloid deposition.

Blood-brain barrier breakdown is linked to tau pathology and neuronal injury in a differential manner according to amyloid deposition.

Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

Published: June 07, 2023

A Multicentre, Randomised, Open-Label, Prospective Study to Estimate the Add-On Effects Of Memantine as Ebixa® Oral Pump (Solution) on Language in Patients with Moderate to Severe Alzheimer's Disease Already Receiving Donepezil (ROMEO-AD).

A Multicentre, Randomised, Open-Label, Prospective Study to Estimate the Add-On Effects Of Memantine as Ebixa® Oral Pump (Solution) on Language in Patients with Moderate to Severe Alzheimer's Disease Already Receiving Donepezil (ROMEO-AD).

Journal: Neurology and therapy

Published: February 18, 2023

Minoxidil Regulates Aging-Like Phenotypes in Rat Cortical Astrocytes In Vitro.

Minoxidil Regulates Aging-Like Phenotypes in Rat Cortical Astrocytes In Vitro.

Journal: Biomolecules & therapeutics

Published: November 10, 2022

Novel Therapeutics for Treating Sleep Disorders: New Perspectives on Maydis stigma.

Novel Therapeutics for Treating Sleep Disorders: New Perspectives on Maydis stigma.

Journal: International journal of molecular sciences

Published: August 31, 2022

Corrigendum to "Glucose deprivation reversibly down-regulates tissue plasminogen activator via proteasomal degradation in rat primary astrocytes" [Life Sci. 92 (2013) 929-937].

Corrigendum to "Glucose deprivation reversibly down-regulates tissue plasminogen activator via proteasomal degradation in rat primary astrocytes" [Life Sci. 92 (2013) 929-937].

Journal: Life sciences

Published: July 19, 2022

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase IIb Clinical Study to Evaluate the Safety and Efficacy of DHP1401 in Patients with Mild to Moderate Alzheimer's Disease Treated with Donepezil: DHP1401 Randomized Trial in Mild to Moderate Alzheimer's Disease (DRAMA).

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase IIb Clinical Study to Evaluate the Safety and Efficacy of DHP1401 in Patients with Mild to Moderate Alzheimer's Disease Treated with Donepezil: DHP1401 Randomized Trial in Mild to Moderate Alzheimer's Disease (DRAMA).

Journal: Journal of Alzheimer's disease : JAD

Published: March 11, 2022

A Multinational, Multicenter, Randomized, Double-Blind, Active Comparator, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Donepezil Transdermal Patch in Patients With Alzheimer's Disease.

A Multinational, Multicenter, Randomized, Double-Blind, Active Comparator, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Donepezil Transdermal Patch in Patients With Alzheimer's Disease.

Journal: Journal of clinical neurology (Seoul, Korea)

Published: March 08, 2022

Validation of the Korean Quick Dementia Rating System (K-QDRS).

Validation of the Korean Quick Dementia Rating System (K-QDRS).

Journal: Journal of Alzheimer's disease : JAD

Published: November 01, 2021

Showing 1-12 of 119

Last Updated: 09/26/2026